AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23841565 — intervention group
Group type: EXPERIMENTAL
Intervention: Refresh
Number of subjects: 43
Study 23841565 — intervention group
Group type: EXPERIMENTAL
Intervention: Systane
Number of subjects: 43
Study 23841565 — intervention group
Group type: EXPERIMENTAL
Intervention: Tears Naturale
Number of subjects: 43
Study 21335621 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring
Number of subjects: 120
Study 21335621 — intervention group
Group type: COMPARATOR
Intervention: Conventional home monitoring with a blood glucose meter and masked continuous glucose monitor
Number of subjects: 120
Study 19576623 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS)
Number of subjects: 113
Study 19576623 — intervention group
Group type: COMPARATOR
Intervention: Surveillance group (Control)
Number of subjects: 113
Study 19576623 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial thickness at trial entry
Number of subjects: 113
Study 17944585 — intervention group
Group type: EXPERIMENTAL
Intervention: oHo (olive oil mixture)
Number of subjects: 32
Study 17944585 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oHo)
Number of subjects: 32
Study 15008714 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical BCG
Number of subjects: 1901
Study 15008714 — intervention group
Group type: COMPARATOR
Intervention: Intravesical mitomycin C
Number of subjects: 1901
Study 15008714 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical BCG (27 mg)
Number of subjects: 1901
Study 15008714 — intervention group
Group type: COMPARATOR
Intervention: Intravesical mitomycin C (30 mg)
Number of subjects: 1901
Study 11339519 — intervention group
Group type: EXPERIMENTAL
Intervention: meloxicam 7.5 mg tablet
Number of subjects: 229
Study 11339519 — intervention group
Group type: COMPARATOR
Intervention: diclofenac 100 mg slow release tablet
Number of subjects: 229
Study 9217822 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream applied once a day for 1 week (n=10)
Number of subjects: 29
Study 9217822 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream applied twice a day for 2 weeks (n=8)
Number of subjects: 29
Study 9217822 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin cream applied once a day for 2 months (n=11)
Number of subjects: 29
Study 9217822 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of betamethasone-17-valerate (once a day) and tretinoin (once a day)
Number of subjects: 29
Study 9217822 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone-17-valerate (once a day)
Number of subjects: 29
Study 8424571 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg intranasal midazolam
Number of subjects: 40
Study 8424571 — intervention group
Group type: COMPARATOR
Intervention: 0.2 ml/5 kg placebo (distilled water)
Number of subjects: 40
Study 3301712 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate energy intake plus exercise (MEEX)
Number of subjects: 0
Study 3301712 — intervention group
Group type: COMPARATOR
Intervention: Low energy intake without exercise (LESD)
Number of subjects: 0
Study 30952217 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking session for 50 minutes
Number of subjects: 40
Study 30952217 — intervention group
Group type: COMPARATOR
Intervention: Quiet-rest control
Number of subjects: 40
Study 27986096 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 240
Study 27986096 — intervention group
Group type: EXPERIMENTAL
Intervention: iRoot BP Plus Root Repair Material (BP‐RRM)
Number of subjects: 240
Study 27986096 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study 26422197 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene-rich tomato extract (30 mg/day)
Number of subjects: 58
Study 26422197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 22945416 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 60
Study 22945416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22945416 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 60
Study 21494604 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E)
Number of subjects: 0
Study 21494604 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS02(D)
Number of subjects: 0
Study 18484235 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (IFNbeta)
Number of subjects: 73
Study 18484235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 16565955 — intervention group
Group type: COMPARATOR
Intervention: Normal-appearing white matter (NAWM) in MS patients
Number of subjects: 64
Study 16565955 — intervention group
Group type: COMPARATOR
Intervention: Cortical gray matter (NAGM) in MS patients
Number of subjects: 64
Study 16565955 — intervention group
Group type: COMPARATOR
Intervention: Regional analyses of NAWM
Number of subjects: 64
Study 16565955 — intervention group
Group type: COMPARATOR
Intervention: Regional analyses of NAGM
Number of subjects: 64
Study 16565955 — intervention group
Group type: EXPERIMENTAL
Intervention: NAGM-ADC histogram peak height in RR/SPMS patients
Number of subjects: 64
Study 15276894 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture plus standardized patient instructors and small-group sessions
Number of subjects: 200
Study 15276894 — intervention group
Group type: COMPARATOR
Intervention: Lecture alone
Number of subjects: 200
Study 10649159 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal massage (10-minute daily massage from 34th to 35th weeks of pregnancy until delivery)
Number of subjects: 759
Study 10649159 — intervention group
Group type: COMPARATOR
Intervention: Control group (no perineal massage)
Number of subjects: 759
Study 10649159 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal massage
Number of subjects: 759
Study 10649159 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 759
Study 9278798 — intervention group
Group type: EXPERIMENTAL
Intervention: rimexolone 1% ophthalmic suspension
Number of subjects: 197
Study 9278798 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 197
Study 8348392 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg/day, increased to max 80 mg/day)
Number of subjects: 298
Study 8348392 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg/day, increased to max 40 mg/day)
Number of subjects: 298
Study 8348392 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin
Number of subjects: 298
Study 8348392 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 298
Study 3799503 — intervention group
Group type: EXPERIMENTAL
Intervention: Se-supplemented group (20 micrograms Se/L)
Number of subjects: 32
Study 3799503 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented group (3-5 micrograms Se/L)
Number of subjects: 32
Study 3799503 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed group
Number of subjects: 32
Study 31682472 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin
Number of subjects: 60
Study 31682472 — intervention group
Group type: EXPERIMENTAL
Intervention: Candida albicans antigen
Number of subjects: 60
Study 31682472 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 60
Study 31570084 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tirofiban treatment within the first 24 hours after IVT
Number of subjects: 187
Study 28080180 — intervention group
Group type: EXPERIMENTAL
Intervention: Five years of tamoxifen
Number of subjects: 4128
Study 28080180 — intervention group
Group type: COMPARATOR
Intervention: Two years of tamoxifen
Number of subjects: 4128
Study 26130744 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus carboplatin (10 mg/kg every 2 weeks and carboplatin AUC 5 every 4 weeks)
Number of subjects: 122
Study 26130744 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab monotherapy (10 mg/kg every 2 weeks)
Number of subjects: 122
Study 26130744 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus carboplatin
Number of subjects: 122
Study 26130744 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab monotherapy
Number of subjects: 122
Study 23319527 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (PA) measured by 7-day accelerometry (counts per minute, cpm)
Number of subjects: 182
Study 23319527 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (PA)
Number of subjects: 182
Study 23319527 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity
Number of subjects: 182
Study 23319527 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activity
Number of subjects: 182
Study 23319527 — intervention group
Group type: COMPARATOR
Intervention: Light activity
Number of subjects: 182
Study 21039930 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA and VC supplementation (ALA: 0, 5, 10 mg/kg; VC: 0, 500 mg/kg)
Number of subjects: 252
Study 21039930 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA and VC supplementation
Number of subjects: 252
Study 21039930 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA supplementation
Number of subjects: 252
Study 21039930 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA or VC supplementation
Number of subjects: 252
Study 21039930 — intervention group
Group type: EXPERIMENTAL
Intervention: VC supplementation
Number of subjects: 252
Study 19609181 — intervention group
Group type: EXPERIMENTAL
Intervention: Group reminiscence sessions (6 to 8 sessions over 2 months)
Number of subjects: 45
Study 19609181 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 45
Study 17569876 — intervention group
Group type: EXPERIMENTAL
Intervention: NXY-059
Number of subjects: 607
Study 17569876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 607
Study 15056525 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (a short-acting benzodiazepine)
Number of subjects: 9
Study 15056525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 11472243 — intervention group
Group type: EXPERIMENTAL
Intervention: Antitumor prodrug monotherapy targeting tumor-associated factors (hypoxia, enzymes, receptors)
Number of subjects: 0
Study 11472243 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodrugs designed for direct recognition of tumor-associated factors
Number of subjects: 0
Study 11472243 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodrugs targeting elevated levels of beta-glucuronidase and tumor-associated proteases
Number of subjects: 0
Study 11472243 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptor-binding motifs coupled to cytotoxic drugs
Number of subjects: 0
Study 9448149 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (3 million U three times weekly for 6 months)
Number of subjects: 24
Study 9448149 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 24
Study 7612090 — intervention group
Group type: EXPERIMENTAL
Intervention: Double phototherapy (n = 19) with irradiance of 33 to 35 microW/cm2/nm in addition to single conventional phototherapy with combination of three or four special blue and white lamps with irradiance of 7 to 9 microW/cm2/nm
Number of subjects: 42
Study 7612090 — intervention group
Group type: COMPARATOR
Intervention: Single conventional phototherapy (n = 23)
Number of subjects: 42
Study 7612090 — intervention group
Group type: EXPERIMENTAL
Intervention: Double phototherapy (n = 19)
Number of subjects: 42
Study 2803885 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed group (normothermia)
Number of subjects: 12
Study 2803885 — intervention group
Group type: COMPARATOR
Intervention: Cold group (routine care)
Number of subjects: 12
Study 2803885 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study 594652 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrizamide (non-ionic contrast medium)
Number of subjects: 12
Study 594652 — intervention group
Group type: COMPARATOR
Intervention: Metrizoate (dissociable contrast medium)
Number of subjects: 12
Study 594652 — intervention group
Group type: EXPERIMENTAL
Intervention: Both contrast media
Number of subjects: 12
Study 31630816 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802
Study 31630816 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 802
Study 31630816 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-DM (NDM) patients
Number of subjects: 802
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplementation (A, B12, C, D, E, K)
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A, C, D, E
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A, B12, C, D, K
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A, D, E, K
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A, C, E
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12
Number of subjects: 0
Study 28167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K
Number of subjects: 0
Study 25740691 — intervention group
Group type: EXPERIMENTAL
Intervention: Balugrastim 300 µg/kg
Number of subjects: 51
Study 25740691 — intervention group
Group type: EXPERIMENTAL
Intervention: Balugrastim 450 µg/kg
Number of subjects: 51
Study 25740691 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 51
Study 25740691 — intervention group
Group type: EXPERIMENTAL
Intervention: Balugrastim (both doses)
Number of subjects: 51
Study 23404963 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 PMR/day
Number of subjects: 36
Study 23404963 — intervention group
Group type: COMPARATOR
Intervention: 1 PMR/day
Number of subjects: 36
Study 22017794 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0
Study 22017794 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-03882845
Number of subjects: 0
Study 22017794 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone and PF-03882845
Number of subjects: 0
Study 22017794 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary Na+/K+ and plasma aldosterone
Number of subjects: 0
Study 19842460 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention to increase physical activity (PA) and reduce sedentary behavior
Number of subjects: 30
Study 19842460 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline measures of PA and TV viewing behaviors
Number of subjects: 30
Study 17341775 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-up and step-down sizing
Number of subjects: 25
Study 17341775 — intervention group
Group type: COMPARATOR
Intervention: Standard sizing
Number of subjects: 25
Study 15481065 — intervention group
Group type: EXPERIMENTAL
Intervention: Kit-based activity intervention
Number of subjects: 37
Study 15481065 — intervention group
Group type: COMPARATOR
Intervention: Time and attention control (one-on-one meetings with an activity therapist)
Number of subjects: 37
Study 11578894 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured preoperative education on the use of PCA
Number of subjects: 60
Study 11578894 — intervention group
Group type: COMPARATOR
Intervention: Standard information given during routine preanesthetic assessment
Number of subjects: 60
Study 9643663 — intervention group
Group type: EXPERIMENTAL
Intervention: Casodex 150 mg/day
Number of subjects: 1453
Study 9643663 — intervention group
Group type: COMPARATOR
Intervention: Castration
Number of subjects: 1453
Study 7930237 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole
Number of subjects: 494
Study 7930237 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulant agents
Number of subjects: 494
Study 7930237 — intervention group
Group type: COMPARATOR
Intervention: Low dose aspirin (50 mg/day)
Number of subjects: 494
Study 2739826 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dopamine infusion (0.1 microgram/kg/min) + hydrosaline retention
Number of subjects: 23
Study 2739826 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention + dl-sulpiride (n = 8)
Number of subjects: 23
Study 2739826 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention + d-sulpiride (n = 7)
Number of subjects: 23
Study 2739826 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention + l-sulpiride (n = 7)
Number of subjects: 23
Study 2739826 — intervention group
Group type: COMPARATOR
Intervention: Low-dose dopamine infusion (0.1 microgram/kg/min)
Number of subjects: 23
Study 31900169 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic device for hand rehabilitation measuring finger strength (flexion and extension)
Number of subjects: 120
Study 31900169 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic device for hand rehabilitation measuring spasticity
Number of subjects: 120
Study 31900169 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic device for hand rehabilitation
Number of subjects: 120
Study 31515667 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg abiraterone acetate taken with a continental breakfast (CB)
Number of subjects: 14
Study 31515667 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg abiraterone acetate taken fasted
Number of subjects: 14
Study 28574605 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (0.8 mg) plus vitamin B12 (0.4 mg)
Number of subjects: 0
Study 28574605 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 (40 mg)
Number of subjects: 0
Study 28574605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26509152 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Volume Low-Pressure (HVLP) cuffs
Number of subjects: 40
Study 26509152 — intervention group
Group type: COMPARATOR
Intervention: Taper-shaped cuffs
Number of subjects: 40
Study 23802809 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 3562
Study 23802809 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3562
Study 21972411 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 360
Study 21972411 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study 19821989 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic family history recording
Number of subjects: 0
Study 19821989 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle advice
Number of subjects: 0
Study 19821989 — intervention group
Group type: COMPARATOR
Intervention: Behavioural interventions targeted at 'at risk' patients
Number of subjects: 0
Study 17224033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 810 nm for 20 seconds
Number of subjects: 22
Study 17224033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 980 nm for 20 seconds
Number of subjects: 22
Study 17224033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 810 nm, repeated 5 times for 20 seconds
Number of subjects: 22
Study 17224033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser irradiation at 980 nm, repeated 5 times for 20 seconds
Number of subjects: 22
Study 17224033 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser irradiation in pulsed mode
Number of subjects: 22
Study 17224033 — intervention group
Group type: COMPARATOR
Intervention: Control (non-irradiated sleeves)
Number of subjects: 22
Study 15499821 — intervention group
Group type: EXPERIMENTAL
Intervention: Mere inflation condition (eyewitness confidence increased over time)
Number of subjects: 450
Study 15499821 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflation + challenge condition (eyewitness aggressively challenged about confidence change)
Number of subjects: 450
Study 15499821 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no evidence of confidence inflation)
Number of subjects: 450
Study 15499821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic participants (N = 360)
Number of subjects: 450
Study 11556942 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician education on diagnosis and optimal management of depression over a 3-month training period.
Number of subjects: 124893
Study 9785069 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 30
Study 9785069 — intervention group
Group type: COMPARATOR
Intervention: 2% mepivacaine
Number of subjects: 30
Study 7908531 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-467
Number of subjects: 0
Study 7908531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3285633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol (DHBP) during premedication
Number of subjects: 206
Study 3285633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol (DHBP) during induction of anesthesia
Number of subjects: 206
Study 3285633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol (DHBP) when patients presented symptoms of nausea and/or vomiting
Number of subjects: 206
Study 3285633 — intervention group
Group type: COMPARATOR
Intervention: No dehydrobenzperidol (Control group)
Number of subjects: 206
Study 31775396 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole mixed berries
Number of subjects: 0
Study 31775396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar matched mixed berry juice
Number of subjects: 0
Study 31775396 — intervention group
Group type: COMPARATOR
Intervention: Sugar matched gelatin
Number of subjects: 0
Study 31775396 — intervention group
Group type: COMPARATOR
Intervention: Sugar/fiber matched gelatin
Number of subjects: 0
Study 31775396 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined berry preparations
Number of subjects: 0
Study 27083384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryton Stent
Number of subjects: 159
Study 27083384 — intervention group
Group type: COMPARATOR
Intervention: Side Branch Balloon Angioplasty (SBBA)
Number of subjects: 159
Study 26639027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfilcon A (NF)
Number of subjects: 76